Get the Stockscreener App
12.04
8.96%
0.99
After Hours:
12.04
Integra Lifesciences Holdings Corp stock is traded at $12.04, with a volume of 1.04M.
It is up +8.96% in the last 24 hours and down -24.18% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$11.05
Open:
$11.07
24h Volume:
1.04M
Relative Volume:
0.90
Market Cap:
$937.82M
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
24.08
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+2.47%
1M Performance:
-24.18%
6M Performance:
-5.12%
1Y Performance:
-47.65%
1-Day Range:
$11.05
$12.31
1-Week Range:
$10.91
$12.31
52-Week Range:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.04 | 860.71M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Yahoo Finance
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Integra LifeSciences Holdings Corporation stock volume spike explainedStop Loss & Expert Verified Movement Alerts - newser.com
Integra LifeSciences (IART) Stock Trades Up, Here Is Why - Finviz
Integra LifeSciences (IART) Gains FDA Clearance for Cardiac Surg - GuruFocus
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device By Investing.com - Investing.com South Africa
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device - Investing.com
Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator in Cardiac Surgery Applications - Quiver Quantitative
Integra (NASDAQ: IART) gets FDA 510(k) for CUSA Clarity in cardiac surgery valve repair - Stock Titan
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock poised for growth2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Insider Buying: Jeffrey Graves Acquires Shares of Integra Lifesc - GuruFocus
[Form 4] INTEGRA LIFESCIENCES HOLDINGS CORP Insider Trading Activity - Stock Titan
Why Integra LifeSciences Holdings Corporation stock attracts global investorsJuly 2025 Weekly Recap & Community Consensus Trade Alerts - Fundação Cultural do Pará
Integra LifeSciences Holdings Corporation stock trend forecastWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call - Yahoo Finance
Will Integra LifeSciences Holdings Corporation (IL3) stock profit from AI boomWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Published on: 2025-11-05 09:55:55 - newser.com
How to use Fibonacci retracement on Integra LifeSciences Holdings CorporationIPO Watch & Weekly Top Stock Performers List - newser.com
Why Integra LifeSciences (IART) Shares Are Trading Lower Today - Yahoo Finance
Integra Lifesciences (IART) Sees Revised Analyst Ratings Today | - GuruFocus
Is Integra LifeSciences Holdings Corporation (IL3) stock a top pick for value investors2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-11-03 05:22:14 - newser.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):